statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	1.464
GB - Regno Unito	223
SG - Singapore	195
CN - Cina	129
SE - Svezia	75
VN - Vietnam	68
HK - Hong Kong	65
BR - Brasile	61
DE - Germania	57
FI - Finlandia	41
IT - Italia	34
FR - Francia	28
RU - Federazione Russa	28
UA - Ucraina	27
TR - Turchia	18
LU - Lussemburgo	16
IN - India	15
CA - Canada	11
KR - Corea	11
BG - Bulgaria	10
AR - Argentina	9
MX - Messico	8
IQ - Iraq	7
PL - Polonia	7
BD - Bangladesh	6
BE - Belgio	6
JP - Giappone	6
AE - Emirati Arabi Uniti	4
CZ - Repubblica Ceca	4
CO - Colombia	3
IE - Irlanda	3
MA - Marocco	3
MY - Malesia	3
PK - Pakistan	3
PY - Paraguay	3
SI - Slovenia	3
CL - Cile	2
EC - Ecuador	2
ET - Etiopia	2
ID - Indonesia	2
JM - Giamaica	2
JO - Giordania	2
KE - Kenya	2
NL - Olanda	2
PT - Portogallo	2
ZA - Sudafrica	2
AL - Albania	1
AQ - Antartide	1
AT - Austria	1
AU - Australia	1
AZ - Azerbaigian	1
CH - Svizzera	1
DK - Danimarca	1
DZ - Algeria	1
ES - Italia	1
GE - Georgia	1
GY - Guiana	1
LT - Lituania	1
ME - Montenegro	1
MO - Macao, regione amministrativa speciale della Cina	1
NI - Nicaragua	1
NO - Norvegia	1
NP - Nepal	1
PE - Perù	1
RS - Serbia	1
SN - Senegal	1
TH - Thailandia	1
TN - Tunisia	1
TW - Taiwan	1
UY - Uruguay	1
UZ - Uzbekistan	1
VE - Venezuela	1
Totale	2.700

Nome	#
New thymidylate synthase inhibitors induce apoptosis in melanoma cell lines	406
Transcriptional profiles in melanocytes from clinically unaffected skin distinguish the neoplastic growth pattern in patients with melanoma	356
CYP450 and GST are induced by xenobiotics in normal human keratinocytes and play a different role in UVB-mediated apoptosis.	284
Cutaneous neonatal lupus erythematosus in four siblings	284
TSI INDUCES APOPTOSIS WITH A P53 INDIPENDENT PATHWAY IN MELANOMA CELL LINES AND IN NORMAL HUMAN MELANOCITES	278
Neonatal Norwegian scabies: three cooperating causes	261
Eruptive squamous cell carcinomas with keratoacanthoma-like features in a patient treated with ruxolitinib	232
New Thymidylate synthase inhibitor induces apoptosis in melanoma cell lines.	220
Pre-surgical basal cell carcinoma margin definition: The SMART approach	199
Identifying locally advanced basal cell carcinoma eligible for treatment with vismodegib: An expert panel consensus	191
Totale	2.711

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	50	0	0	0	0	0	0	0	0	0	31	9	10
2021/2022	206	8	26	15	13	2	16	7	10	18	12	52	27
2022/2023	248	34	37	12	31	23	51	2	11	38	2	4	3
2023/2024	127	3	7	5	10	42	18	5	21	2	0	1	13
2024/2025	455	21	6	44	32	87	57	16	32	41	18	40	61
2025/2026	776	62	20	54	95	213	66	91	34	90	51	0	0
Totale													2.711